Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

Doximity has been a top-rated stock at MAPsignals. That means the stock has unusual buy pressure and growing fundamentals. We ...

Benjamin Regina M., a director at Doximity , Inc. (NYSE:DOCS), recently sold a significant portion of the company's Class A Common Stock. According to a recent SEC filing, Regina sold shares worth ...

Jefferies analyst Glen Santangelo increased the price target for Doximity Inc (NYSE:DOCS) to $88 from $64, while continuing to recommend the stock as a Buy. Santangelo noted that the stock has ...

It also should prompt conservatives to address their human-capital problem: without right-wing academics, there are fewer ...

Doximity, Inc. is growing faster than even management expected while scaling costs and returning customers better than the ...

What’s the full story? Baird is here to talk about FTNT, the stock that’s been oscillating between “rocket ship” and “meh” like a crypto bro trying to explain utility tokens. In 2024, FTNT was the ...

Goldman Sachs analyst David Roman raised the firm’s price target on Doximity (DOCS) to $80 from $58 and keeps a Neutral rating on the shares ...